Clinical trial
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive…
NCT00201838 · Ohio State University Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00201838 |
|---|---|
| Title | Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma |
| Official title | A Phase I/II Study of Etanercept and Gemcitabine in Patients With Advanced Stage and Chemotherapy Naive Pancreatic Adenocarcinoma |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Collaborators | Immunex Corporation Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Neoplasms, Adenocarcinoma |
| Intervention type | Drug |
| Interventions | Gemcitabine, Etanercept |
| Enrollment | 38 |
| Start date | Jul 1, 2001 |
| Primary completion | Oct 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: